Literature DB >> 8370581

Spectrin alpha IIa variant in dominant and non-dominant spherocytosis.

P Boivin1, C Galand, I Devaux, M C Lecomte, M Garbarz, D Dhermy.   

Abstract

Several polymorphic mutations are located on the spectrin alpha-chain; among these the variant termed alpha IIa is characterized by an acid shift in the isoelectric point of the tryptic digest peptides 46 kDa and 35 kDa. In this variant a single amino acid substitution (alanine to aspartic acid) occurred at position 972 of the spectrin alpha-chain due to a point mutation (GCT to GAT) in the DNA. This variant, which seemed very rare in normal people, could be related to the recessive form of hereditary spherocytosis (HS) and could be absent in the dominant form of the disease. We have studied the alpha IIa variant by denaturing electrophoresis of the spectrin tryptic digest peptides from 179 subjects: 46 controls, 78 patients with dominant (d) or non-dominant (nd) HS and 55 relatives of the patients. The confirmation of the results was obtained at the DNA level in 41 subjects. The frequency of the chromosome bearing the alpha IIa mutation was 7.6% in controls and higher (about 12-14%) in members of families with dHS as well ndHS. However, the family trees clearly showed that the mutation and the HS disease gene(s) were located on different chromosomes and inherited independently from each other. Furthermore, our study allows the conclusion that in most (if not all) cases of dHS, the alpha IIa the variant is not the cause, is not a marker, and does not influence the phenotypic expression of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370581     DOI: 10.1007/bf00219683

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

Authors:  J T DODGE; C MITCHELL; D J HANAHAN
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

Review 2.  Clinical and molecular aspects of disorders of the erythrocyte membrane skeleton.

Authors:  P G Gallagher; W T Tse; B G Forget
Journal:  Semin Perinatol       Date:  1990-10       Impact factor: 3.300

3.  Full-length sequence of the cDNA for human erythroid beta-spectrin.

Authors:  J C Winkelmann; J G Chang; W T Tse; A L Scarpa; V T Marchesi; B G Forget
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance.

Authors:  M R Clark; N Mohandas; S B Shohet
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

7.  Deficient red-cell spectrin in severe, recessively inherited spherocytosis.

Authors:  P Agre; E P Orringer; V Bennett
Journal:  N Engl J Med       Date:  1982-05-13       Impact factor: 91.245

8.  A structural model of human erythrocyte spectrin. Alignment of chemical and functional domains.

Authors:  D W Speicher; J S Morrow; W J Knowles; V T Marchesi
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

9.  Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis.

Authors:  P Agre; A Asimos; J F Casella; C McMillan
Journal:  N Engl J Med       Date:  1986-12-18       Impact factor: 91.245

10.  Partial deficiency of erythrocyte spectrin in hereditary spherocytosis.

Authors:  P Agre; J F Casella; W H Zinkham; C McMillan; V Bennett
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

View more
  3 in total

1.  Combination of two mutant alpha spectrin alleles underlies a severe spherocytic hemolytic anemia.

Authors:  H Wichterle; M Hanspal; J Palek; P Jarolim
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

2.  Facilitating EMA binding test performance using fluorescent beads combined with next-generation sequencing.

Authors:  Andreas Glenthøj; Christian Brieghel; Amina Nardo-Marino; Richard van Wijk; Henrik Birgens; Jesper Petersen
Journal:  EJHaem       Date:  2021-09-09

3.  A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis.

Authors:  P B Jenkins; G K Abou-Alfa; D Dhermy; E Bursaux; C Féo; A L Scarpa; S E Lux; M Garbarz; B G Forget; P G Gallagher
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.